Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when VRDN files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsViridian Therapeutics completes routine 2026 Annual Meeting with all proposals approved
Filed June 3, 2026 · Period ending June 2, 2026 · ~1 min read
Key Changes
-
low
Stockholders elected two Class II directors (Tomas Kiselak and Jennifer K. Moses) to serve three-year terms through 2029, with Moses receiving 99.5% support and Kiselak receiving 83% support.
Item 5.07 verify on EDGAR → -
low
Executive compensation received 96% stockholder approval in advisory say-on-pay vote, with 83.5 million votes in favor versus 3.1 million against.
Item 5.07 verify on EDGAR → -
low
Board adopted annual frequency for future say-on-pay votes following stockholder preference, meaning executive compensation will face advisory vote each year.
Item 5.07 verify on EDGAR → -
low
KPMG LLP ratified as independent auditor for fiscal 2026 with 99% approval (92.9 million votes for).
Item 5.07 verify on EDGAR →
Summary
Viridian Therapeutics held its 2026 Annual Meeting on June 2, with stockholders approving all routine governance matters. The meeting covered standard annual business: electing directors, ratifying the auditor, and voting on executive compensation. All proposals passed with strong support, indicating general stockholder satisfaction with management and board oversight.
For retail investors, this filing represents routine corporate housekeeping with no material business developments. The high approval rates—particularly the 96% support for executive pay and near-unanimous auditor ratification—suggest no significant governance concerns among the shareholder base. The board's adoption of annual say-on-pay votes aligns with common corporate governance practices. Watch for the company's proxy statement later this year, which will detail any changes to executive compensation structure or board composition for the 2027 annual meeting cycle.
Section-by-Section Diff
Event · Item 5.07 — Submission of Matters to a Vote of Security Holders
Viridian held its 2026 Annual Meeting; all director nominees elected, auditor ratified, say-on-pay approved, annual frequency chosen.
Show 4 minor / wording changes
Added in current filing · verify on EDGAR →
At the Annual Meeting, each of the Company’s director nominees was elected and the other proposals voted on were approved.
Two Class II directors were elected to serve until 2029: Tomas Kiselak received 72,363,500 votes for with 14,475,646 withheld, and Jennifer K. Moses received 86,378,842 votes for with 460,304 withheld. Both nominees were elected by stockholders.
Added in current filing · verify on EDGAR →
Ratification of the selection of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026:
For | Against | Abstentions | Broker Non-Votes | 92,866,008 | 512,582 | 193,660 | —
Stockholders ratified KPMG LLP as the independent auditor for fiscal year 2026 with 92,866,008 votes for, 512,582 against, and 193,660 abstentions. This is a routine annual vote confirming the audit firm.
Added in current filing · verify on EDGAR →
Approval, on an advisory basis, of the compensation of the Company’s named executive officers:
For | Against | Abstentions | Broker Non-Votes | 83,512,086 | 3,113,724 | 213,336 | 6,733,104
Stockholders approved executive compensation on an advisory basis with 83,512,086 votes for, 3,113,724 against, and 213,336 abstentions. This non-binding vote shows approximately 96% stockholder support for the company's executive pay practices.
Added in current filing · verify on EDGAR →
As a result of the foregoing vote, the Company’s Board of Directors has determined that the Company will conduct a non-binding advisory vote on the compensation of the Company’s named executive officers every year.
Stockholders voted on how often to hold say-on-pay votes, with 86,084,347 choosing annual frequency. The Board adopted this preference, meaning executive compensation will be subject to an advisory stockholder vote every year going forward.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify